Seeking Alpha

Impax Laboratories (IPXL +0.1%) bucks a weak tape on positive comments out of Canaccord this...

Impax Laboratories (IPXL +0.1%) bucks a weak tape on positive comments out of Canaccord this morning. The firm says there are a number of positive catalysts down the road that will likely drive the stock higher, including: remediation of the FDA's warning letter; an Adderall XR settlement with Shire (SHPGY); and the pending FDA decision on it's Parkinson's disease drug Rytary which is due October 21.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs